ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

AMPH Amphastar Pharmaceuticals Inc

39.97
-0.52 (-1.28%)
Last Updated: 10:42:21
Delayed by 15 minutes

Period:

Draw Mode:

Volume 62,182
Bid Price 39.97
Ask Price 40.00
News -
Day High 40.83

Low
38.43

52 Week Range

High
67.66

Day Low 39.96
Share Name Share Symbol Market Stock Type
Amphastar Pharmaceuticals Inc AMPH NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.52 -1.28% 39.97 10:42:21
Open Price Low Price High Price Close Price Previous Close
40.49 39.96 40.83 40.49
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,372 62,182 US$ 40.28 US$ 2,504,900 - 38.43 - 67.66
Last Trade Type Quantity Price Currency
10:42:20 6 US$ 39.97 USD

Amphastar Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.93B 48.10M - 644.4M 137.55M 2.86 14.03
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Amphastar Pharmaceuticals News

Date Time Source News Article
6/11/202417:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/11/202417:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/10/202415:51Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
6/05/202418:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/05/202417:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/05/202417:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/05/202417:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/04/202415:14Edgar (US Regulatory)Form 8-K - Current report
6/03/202415:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/08/202415:18Edgar (US Regulatory)Form 8-K - Current report
3/08/202415:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/08/202415:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AMPH Message Board. Create One! See More Posts on AMPH Message Board See More Message Board Posts

Historical AMPH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week40.2641.9339.7140.95337,382-0.29-0.72%
1 Month43.5244.1439.7141.86328,045-3.55-8.16%
3 Months44.0446.61538.4341.76348,149-4.07-9.24%
6 Months57.3365.924938.4348.59418,960-17.36-30.28%
1 Year55.5067.6638.4350.91431,766-15.53-27.98%
3 Years20.1767.6617.5639.51361,09019.8098.17%
5 Years19.9467.6612.32533.46305,13320.03100.45%

Amphastar Pharmaceuticals Description

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Your Recent History

Delayed Upgrade Clock